SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending after the National Comprehensive Cancer Network updated its clinical guidelines to include ANKTIVA for a broader range of bladder cancer patients, signaling a significant expansion of the drug's eligible treatment population. The community is buzzing over this potential catalyst for increased insurance coverage and revenue, while actively discussing the long-term outlook for the company's immunotherapy platform as it gains momentum in both clinical and international markets.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is surging following a positive clinical update that highlights an annual recurrence rate of less than 1% in the open-label arm of its Phase III trial, fueling community optimism about the company's competitive position. Investors are actively discussing the trial's statistically significant results compared to industry standards, the high level of insider ownership, and growing anticipation for upcoming abstract presentations.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging following a massive five-year, $27 billion AI infrastructure deal with Meta, which builds on a recent $2 billion equity investment from Nvidia. The community is heavily focused on the company's rapid hyperscaler expansion, debating the implications of this contract for future revenue and whether the stock's valuation is poised for a sustained breakout or a potential pullback.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is currently trading in a tight consolidation range as investors weigh record-breaking revenue and strong AI infrastructure demand against margin compression concerns and lingering sentiment around historical accounting reports. The community is actively debating the company's long-term value, with many hopeful that upcoming industry conferences and strategic NVIDIA ecosystem partnerships will finally catalyze a breakout from the stock's multi-month sideways trend.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is facing significant operational headwinds as a prolonged government shutdown triggers mandatory flight capacity cuts and widespread cancellations, putting pressure on industry profit guidance. Despite these challenges, market sentiment remains cautiously optimistic as investors monitor the impact of rising fuel costs against the backdrop of robust travel demand and resilient corporate booking trends.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is drawing significant investor attention due to a surge in trading volume and speculation regarding a potential short squeeze, fueled by its pivot toward stablecoin settlement and institutional infrastructure. The community is actively discussing recent corporate developments, including share dilution, and is keenly anticipating an upcoming Investor Day that many hope will clarify the company's long-term growth strategy.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

Ripple's XRP is trending as traders closely monitor its recent price action and resistance levels, with many community members debating whether the current move is a sustainable breakout or another manipulation trap. The conversation is heavily polarized between long-term holders citing institutional adoption and potential utility, and skeptics who remain wary of market volatility and its historical correlation with broader crypto movements.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

The XRP community is currently polarized as the Bitwise XRP ETF launch drives intense debate over its role in institutional adoption versus speculative price manipulation. Traders remain divided between those aggressively buying into the current price volatility and others expressing deep skepticism about the asset's long-term utility and historical price action.

Coda Octopus Group, Inc. engages in the developing, manufacturing, and marketing of subsea products. The firm operates through the following segments: Marine Technology Business (Products), Acoustics Sensors and Materials Business (PAL), and Defense Engineering Services Business. The Marine Technology Business segment develops solutions for subsea and underwater markets. The Acoustics Sensors and Materials Business segment engages in the provision of a comprehensive range of products and solutions, with a primary focus on medical imaging and Non-Destructive Testing. The Defense Engineering Services Business segment engages in defense contractors and designs, engineers, manufactures and supplies proprietary sub-assemblies for incorporation into broader mission critical defense systems. It also operates through the Americas, Europe, Australia or Asia, and Middle East or Africa geographical segments. The company was founded in 1994 and is headquartered in Orlando, FL.

Coda Octopus Group Inc.

Coda Octopus Group is gaining traction as investors focus on its proprietary real-time 3D sonar technology, which is increasingly critical for subsea infrastructure, defense, and maritime security. The community is actively discussing the stock's multi-bagger potential, high institutional interest, and the significant demand for its specialized equipment in global underwater operations.

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Bicycle Therapeutics Plc - ADR

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Likely ETF Winners & Losers From Winter Storm Fern

Winter Storm Fern rattles the United States, lifting heating demand and natural gas prices as UNG stands out while airlines and consumers face headwinds.

<ul class="summary-bullets"><li>CEO Stephen Hemsley released a prepared testimony ahead of his appearance before the Energy and Commerce Subcommittee on Health later this week.</li><li>Hemsley called on lawmakers to pursue broader reforms to health savings accounts, care delivery rules, patent laws, and drug pricing to improve healthcare affordability.</li><li>UnitedHealth negotiated nearly $300 billion in discounts in 2025, Hemsley said.</li></ul>UnitedHealth Group Inc. (UNH) plans to refund profits from its Affordable Care Act (ACA) plans, famously known as Obamacare, to customers in 2026, a move that comes as Congress debates whether to extend enhanced tax credits that support those plans.The announcement was made by chief executive officer Stephen Hemsley in a prepared testimony released ahead of his appearance before the United States House of Representatives Committee on Energy &amp; Commerce, Subcommittee on Health, later this week.Earlier this month, the U.S. House of Representatives voted to extend ACA subsidies for another three years. The measure passed 230–196, with support from 213 Democrats and 17 Republicans, renewing Obamacare tax credits that had expired at the end of 2025. The bill now heads to the Senate for further consideration.Insurers have faced mounting pressure from President Donald Trump, who has opposed extending the additional ACA subsidies.“Though UnitedHealthcare is a relatively small participant in the individual ACA market, we will voluntarily eliminate and rebate our profits this year for these coverages,” Hemsley’s statement read.<h2 class="st-heading-2">Thin Margins</h2>UnitedHealth executives have previously described ACA margins as thin. Chief Financial Officer Wayne DeVeydt said in November that the business was expected to generate “low single-digit” margins. The company also raised ACA premiums by an average of 25% for 2026.Hemsley urged lawmakers to consider broader reforms, including changes to health savings accounts, site-of-care rules, patent laws, and drug pricing, to help make healthcare more affordable and sustainable over time.In the prepared testimony, Hemsley emphasized broader cost pressures across the U.S. healthcare system, noting that healthcare spending per person has surged over the past 25 years, driven by rising hospital prices, prescription drug costs, and specialty care. He highlighted UnitedHealth’s efforts to mitigate those pressures, including negotiating nearly $300 billion in discounts last year.At the time of writing, <a href="https://stocktwits.com/symbol/UNH">UNH stock</a> was up 2.4% while shares of insurers with heavier exposure to ACA coverage dropped sharply, with <a href="https://stocktwits.com/symbol/CNC">Centene Corp shares</a> sliding 2.4% and <a href="https://stocktwits.com/symbol/OSCR">Oscar Health stock</a> falling 7%.<h2 class="st-heading-2">Potentially Masterful Move</h2>Baird sees UnitedHealth's plan to rebate its ACA profit to customers as a “potentially masterful move”.&nbsp; If the company’s announcement leads the government to implement health exchange profit rebate measures, “this could be a masterful chess move in placing potential pressure on competitor HIX plans who heavily rely on these profits in 2026,” the brokerage added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for UNH changed to ‘neutral’ from ‘extremely bearish’ a day earlier. One Stocktwits user highlighted the company’s strength.<stembedurl>https://stocktwits.com/dan4100/message/642413792</stembedurl>Another user sees a move beyond the $350 and $367 levels, leading to a rally toward $400. The stock is currently trading at $345.8.<stembedurl>https://stocktwits.com/SlickBrag/message/642424684</stembedurl>Over the past year, UNH shares have declined by around 33%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-pavm-stock-surge-today/cmUDHKRR4fS">PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the UnitedHealth Group logo is displayed on the screen of a smartphone. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

UnitedHealth Pledges ACA Profit Rebates Amid Subsidy Debate – But Retail Sees Rally Toward $400 

UnitedHealth Group Inc. plans to rebate profits from its Affordable Care Act plans, also known as Obamacare, to customers in 2026.

Equity

<ul class="summary-bullets"><li>Acquisition of RPD Technologies, a Houston-based R&amp;D firm focused on refining, petrochemical, and renewable technologies, will boost the company’s expansion plans.</li><li>The company said Phase 2 of the waste plastics-to-renewable fuels and chemicals plant is expected to be completed in 2029.</li><li>Recently, the company secured expanded rights to Alterra Energy’s recycling technology.</li></ul>Abundia Global Impact Group Inc. (AGIG) stock saw strong buying interest with the shares popping 25% on Tuesday, after a letter to the shareholders highlighted key objectives for the year.Abundia said it expects to complete the acquisition of RPD Technologies, a Houston-based Research and Development (R&amp;D) firm focused on refining, petrochemical, and renewable technologies, by the first quarter (Q1) of 2026. The acquisition is expected to boost the company’s expansion plans.In the second-quarter (Q2), the company is targeting completion of Phase 1 at the Cedar Port Innovation Center, which will serve as its operational headquarters, technology hub, and R&amp;D facility and the “central command” for renewable fuel commercialization.Based on current plans, Phase 2 of the waste plastics-to-renewable fuels and chemicals plant is expected to be completed in 2029, the company added. It anticipates commercial production and revenue to begin the same year. Sales of sustainable aviation fuel will depend on completing the required certification.Recently, the company secured expanded rights to Alterra Energy’s recycling technology, allowing it to develop and operate two additional plastics recycling sites in the U.S.Last year, the company began trading on the NYSE American under the ticker <a href="https://stocktwits.com/symbol/AGIG">AGIG</a>, after the acquisition of Abundia Global Impact Group and the transition from its former name, Houston American Energy Corp.Abundia 2025 highlights include the acquisition of the Cedar Port site in Texas to anchor its innovation hub and the launch of Phase 1 development.&nbsp;The company also secured key engineering and technology partners, including a sustainable aviation fuel (SAF) agreement with BTG Bioliquids, strengthened its balance sheet, and raised $8 million in capital, it added.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/fda-letter-on-suicide-warning-on-weighloss-drugs/cmUXfeaR4IJ">FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

AGIG Stock Up Nearly 30% - What Triggered The Rally Today?

Abundia highlighted key objectives for the year, including the acquisition of RPD Technologies by the first-quarter and the completion of Phase 1 at the Cedar Port Innovation Center by second-quarter.

<ul class="summary-bullets"><li>Ever since late October, UNH stock has been in a corrective mode, sliding from its high of $381 following its third-quarter earnings.</li><li>UNH has stayed below its 200-day moving average since mid-April.</li><li>Insurance stocks gained on Thursday after the U.S. Senate rejected both Republican and Democratic proposals to address expiring healthcare subsidies.</li></ul>UnitedHealth Group Inc. (UNH) shares have drawn heavy interest from retail investors on Friday morning as it appears set to clear a key hurdle at $340 following the U.S. Senate’s rejection of Republican and Democratic proposals to address expiring healthcare subsidies.The $340 mark coincides with the stock’s 50-day moving average (50-DMA), currently at around $340.71 – a key hurdle which, if crossed, will be considered as a positive signal for the short term. Ever since late October, UNH stock has been in a corrective mode, sliding from its high of $381 following its third-quarter earnings.&nbsp;<figure class="image"><img style="aspect-ratio:1315/927;" src="https://news.stocktwits-cdn.com/UNH_png_a079cadf0a.webp" alt="UNH.png" width="1315" height="927"><figcaption>UNH-50 DMA on Dec. 11, 2025 | Source: Stocktwits</figcaption></figure>Though revenue rose 12% to $113.2 billion in the quarter, higher medical costs and Medicare funding cuts pressured profits. Net income dropped to $2.54 billion from $6.56 billion, and net margins slid sharply to 2.1% from 6%. The stock has stayed below its 200-day moving average since mid-April.<h2 class="st-heading-2">The Healthcare Plan Deadlock</h2>On Thursday, insurance stocks rose after the U.S. Senate rejected proposals to address expiring healthcare subsidies. Although ACA premiums are expected to increase and tax credits are ending this year, investors had largely priced in the impact. They reportedly viewed the Republican plan as the bigger risk.That plan would eliminate the enhanced tax credits and instead put the funds into Health Savings Accounts for those buying bronze or “catastrophic” ACA plans, providing $1,000 for individuals aged 18 to 49, and $1,500 for those aged 50 to 64.<h2 class="st-heading-2">UnitedHealth’s Financial Plans</h2>Last month, UnitedHealth launched a three-year turnaround plan aimed at restoring profitability and what the new CFO, Wayne DeVite, described as the company’s “swagger” by 2027. The strategy includes dropping unprofitable Medicare Advantage and ACA plans, and sharpening its focus on U.S. operations.UnitedHealth also priced its 2026 plans with a higher 10% medical-cost trend to address inflation pressures. As part of the overhaul, the company plans to sell non-core international assets, reduce debt, and resume share buybacks in late 2026. It has already agreed to sell its final South American asset, Banmedica, to Patria Investments for about $1 billion.Despite raising its 2025 profit outlook and signaling strong momentum into 2026 and 2027, the company still faces elevated medical costs, especially in its Medicaid business.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits shifted to ‘bearish’ from ‘extremely bearish’ a day earlier. <a href="https://stocktwits.com/symbol/UNH">UNH</a> was also among the top trending tickers on the platform.One user sees $340 as a crucial level. The stock is currently near $338.<stembedurl>https://stocktwits.com/RockyTSTH/message/638961001</stembedurl>Year-to-date, the stock has declined more than 33%.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/robert-reich-warns-trump-grip-on-private-sector-paramount-netflix-battle-wbd/cLIChD0REFi">Robert Reich Sounds Alarm: Trump’s Grip On Private Sector In Spotlight As Paramount, Netflix Battle For WBD Heats Up</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

UNH Shares Appear Set For Potential Breakout Above $340 –  Why It’s Crucial For The Stock To Clear This Key Hurdle?

The $340 mark coincides with the stock’s 50-day moving average (50-DMA), currently at around $340.71 – a key hurdle which, if crossed, will be considered as a positive signal for the short term.

Build Buffett's Berkshire-Like Portfolio With These ETFs

Build a Buffett-style portfolio with ETFs. Berkshire's latest moves spotlight GOOGL, staples, insurance picks and ETFs like GXPC, FCOM, IYK, PBJ, IAK and KBWP.



Should You Invest in the iShares U.S. Insurance ETF (IAK)?

Should You Invest in the SPDR S&P Insurance ETF (KIE)?

Should You Invest in the Invesco KBW Property & Casualty Insurance ETF (KBWP)?

Is Wall Street Bullish or Bearish on American International Group Stock?

Insurance giant AIG has notably outperformed the broader market in recent months, and analysts remain moderately bullish on the stock’s prospects.

Aflac Stock: Analyst Estimates & Ratings

Aflac has surpassed the broader market over the past year, and analysts remain cautious about its future prospects.

IAK
iShares U.S. Insurance ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IAK News

IAKiShares U.S. Insurance ETF